sc13g


	OMB APPROVAL
	OMB Number: 3235-0145
	Expires: February 28, 2009
	Estimated average burden hours per response ... 10.4

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

StatSure Diagnostic Systems, Inc.

(Name of Issuer)

Common Stock, $0.001

(Title of Class of Securities)

795427202

(CUSIP Number)

October 20, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

	o		Rule 13d-1(b)

	þ		Rule 13d-1(c)

	o		Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

TABLE OF CONTENTS


	Item 1.
	Item 2.
	Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
	Item 4. Ownership
	Item 5. Ownership of Five Percent or Less of a Class
	Item 6. Ownership of More than Five Percent on Behalf of Another Person
	Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
	Item 8. Identification and Classification of Members of the Group
	Item 9. Notice of Dissolution of Group
	Item 10. Certification
Signature


CUSIP No.		795427202	13G	Page		2		of		5 Pages


1	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Inverness Medical Innovations, Inc.


2	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a) o
	(b) þ

3	SEC Use Only



4	Citizenship or Place of Organization

	Delaware

		5	Sole Voting Power

Number of			2,499,999

Shares		6	Shared Voting Power
Beneficially
Owned by			0

Each		7	Sole Dispositive Power
Reporting
Person			2,499,999

With		8	Shared Dispositive Power

			0

9	Aggregate Amount Beneficially Owned by Each Reporting Person

	2,499,999

10	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

	o

11	Percent of Class Represented by Amount in Row (9)

	6.1%

12	Type of Reporting Person (See Instructions)

	CO


CUSIP No.		795427202		Page		3		of		5 Pages

Item 1.

(a) Name of Issuer: StatSure Diagnostic Systems, Inc. (the “Issuer”).

(b) Address of the Issuer’s Principal Executive Offices: 1881 Worcester Road, #200, Framingham, MA 01701.

Item 2.

(a) Name of Person Filing: Inverness Medical Innovations, Inc.

(b) Address of Principal Business Office: 51 Sawyer Road, Suite 200, Waltham, MA 02453.

(d) Title and Class of Securities: Common stock, $0.001 (“Common Stock”)

(e) CUSIP Number: 795427202

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

Item 4. Ownership

In the aggregate, as of October 20, 2007, the Reporting Person beneficially owns 2,499,999 shares of Common Stock of the Issuer, representing approximately 6.1% of the class. The beneficial ownership of the Reporting Person includes:

	(i)		1,428,571 shares of the issued and outstanding Common Stock; and

	(ii)		a warrant to acquire 1,071,428 shares of Common Stock.

The Reporting Person has (or will have) the sole power to vote and dispose of all such beneficially owned shares.

Item 5. Ownership of Five Percent or Less of a Class

Not applicable

Item 6. Ownership of More than Five Percent on Behalf of Another Person

Not applicable

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not applicable


CUSIP No.		795427202		Page		4		of		5 Pages

Item 8. Identification and Classification of Members of the Group

Not applicable

Item 9. Notice of Dissolution of Group

Not applicable

Item 10. Certification

By signing below I hereby certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose.


CUSIP No.		795427202		Page		5		of		5 Pages

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


		DATE: December 21, 2007

		INVERNESS MEDICAL INNOVATIONS, INC.

		By:		/s/ Jay McNamara

		Jay McNamara Senior Counsel—Corporate & Finance

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents